NRXP Stock Analysis: Buy, Sell, or Hold?
NRXP - NRX Pharmaceuticals, Inc. Common Stock
$4.15
-0.04 (-0.95%)
▼
5d:
+5.2%
30d:
+10.37%
90d:
+86.94%
BUY
HIGH Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 17, 2026
Get Alerted When NRXP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: NRXP trading at deep discount. Market pricing in -6.6% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: NRXP trading at deep discount. Market pricing in -6.6% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$7.15
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$4.44
6.5% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NRXP is currently trading at $4.15, which is considered slightly high relative to its 30-day fair value range of $3.77 to $4.13. From a valuation perspective, the stock is trading at a discount (Forward PE: 8.3) compared to its historical average (10.2). Remarkably, the market is currently pricing in an annual earnings decline of 6.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, NRXP is in a strong uptrend. Immediate support is located at $3.45, while resistance sits at $5.05.
Market Sentiment: NRXP has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $42.00 (+912.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, NRXP is in a strong uptrend. Immediate support is located at $3.45, while resistance sits at $5.05.
Market Sentiment: NRXP has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $42.00 (+912.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$3.77 -
$4.13
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
76.2%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 912.0% below Wall St target ($42.00)
Trading Range Analysis
30-Day Trading Range
$3.77 -
$4.13
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$3.45
Resistance Level
$5.06
Current Trend
Strong Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
8.30
Wall Street Target
$42.00
(+912.0%)
Valuation Discount vs History
-6.6% cheaper
PE vs Historical
8.3 vs 10.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-6.6%
(market-implied from PE analysis)
1-Year Target
$3.88
(-7%)
2-Year Target
$3.62
(-13%)
3-Year Target
$3.38
(-19%)
3-Yr Target (if PE normalizes)
(PE: 8→10)
$4.16
(+0%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 8.3 to 10.2
Stabilization Target:
$5.10
(+22.9%)
PE Expansion Potential:
+22.9%
Share & Embed Analysis
Last updated: July 13, 2026 8:44 PM ET
Data refreshes hourly during market hours. Next update: 9:44 PM
Data refreshes hourly during market hours. Next update: 9:44 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NRXP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$441 | 60 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$102 | 67 BUY |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$258 | 67 BUY |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$22 | 59 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 59 HOLD |
Advanced NRXP Option Strategies
Professional options setups generated by AI based on today's NRXP price and gamma walls.
